The heart’s atria play a critical role in maintaining healthy circulation and rhythm. When the atrial walls undergo structural changes, known as atrial remodeling, it can increase the risk of arrhythmias, stroke, and heart failure. By combining molecular and metabolic biomarkers, the CARMD-Dx Test provides an advanced assessment of atrial health, remodeling risk, and cardioembolic potential.

This test offers actionable insights for patients with cardiovascular disease, athletes, and those at risk for atrial fibrillation, embolic stroke, or other cardiac events.

Why CARMD-Dx Matters

Key Benefits

Advancing brain health with early, non-invasive insights

Early Risk Identification

Detects molecular changes associated with atrial remodeling before symptoms develop.

Stroke Prevention

Identifies cardioembolic risk markers that support proactive intervention.

Athlete Heart Health

Distinguishes between healthy adaptation to training and pathological remodeling.

Precision Care

Provides biomarker-based guidance for personalized cardiovascular management.

Offered Clinical Interpretation Services

Interpretations

Focused on cardiovascular health, this test measures molecular signatures of atrial stress and cardioembolic risk, helping to prevent stroke and other cardiovascular events.

Clinical Interpretation Services:

Lorem ipsum dolor sit amet, consectetur adipiscing elit.

Register now for the Blood–Brain Barrier Neurovulnerability Test (BBBNeuro-Dx) to gain early insights into brain protection and uncover hidden risks for neurological disease.

Register now